Avid Bioservices Inc (CDMO)

[sulaco]

Biopharm, immunotherapy IS the future of oncology


You're right. Ignore clueless shorts. Bavi has the potential to split BIG TIME.

It is the BROAD BASE PLATFORM of Bavi that so few outside this board "get."

Chemotherapy has fried the immune system for so long, it can actually cause a cancer as it tries to cure one (loss of immuno- surveillance).

That's why when you see TV commericals for immuno-suppresant drugs for rheumatoid arthitis or psoriasis (like Enbrel, Humira), they always have to mention the risk of LYMPHOMA.

Look, Garnick sums it up perfectly:

Since I joined Peregrine last year, I’ve worked closely with the team here to develop a comprehensive clinical, regulatory, and manufacturing strategy for bavituximab, similar to what I used successfully for Avastin while I was at Genentech. And as you know, Avastin was the first broad-spectrum anti-cancer agent, and in my mind bavituximab could be potentially very similar to Avastin because of the broad presence of bavituximab phosphatidylserine target in numerous cancers.

This is the FINEST, most ELOQUENT summary of why I'm invested in Bavi/PPHM. Thank you Dr. Garnick.

Keep up the great work, Bio.

Best,

Joe